BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 17900277)

  • 21. Weak D type 2 is the most prevalent weak D type in Portugal.
    Araújo F; Rodrigues MJ; Monteiro F; Chabert T; Tavares G; Sousa G; Storry J; Guimarães JE
    Transfus Med; 2006 Feb; 16(1):63-7. PubMed ID: 16480441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [External national quality control of blood group typing 1983-92. Significance for quality assurance in transfusion medicine].
    Heier HE; Kornstad L
    Tidsskr Nor Laegeforen; 1993 Oct; 113(25):3155-8. PubMed ID: 8273042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of weak D with a fully automated solid-phase red cell adherence system.
    Lai M; Mavilia G; d'Onofrio G; Leone G
    Transfusion; 2005 May; 45(5):689-93. PubMed ID: 15847655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular genetic blood group typing by the use of PCR-SSP technique.
    Prager M
    Transfusion; 2007 Jul; 47(1 Suppl):54S-9S. PubMed ID: 17593287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal reagents for rhesus-D typing of Irish patients and donors: a review.
    Williams M
    Br J Biomed Sci; 2000; 57(2):142-9. PubMed ID: 10912289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The RHCE allele ceSL: the second example for D antigen expression without D-specific amino acids.
    Chen Q; Hustinx H; Flegel WA
    Transfusion; 2006 May; 46(5):766-72. PubMed ID: 16686844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel RHD alleles with weak hemagglutination and genetic Exon 9 diversity: weak D Types 45.1, 75, and 76.
    Gassner C; Utz I; Schennach H; Ramoni A; Steiner H; Scholz S; Kreklau U; Körmöczi GF
    Transfusion; 2013 Nov; 53(11 Suppl 2):2954-9. PubMed ID: 23550956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serologic profiling of D variants in donor routine: unveiling the impact on false-negative results and alloimmunization.
    Arnoni CP; Vendrame TA; Silva FS; Silva NM; Cortez A; Latini F; Castilho L
    Immunohematology; 2024 Jun; 40(2):47-53. PubMed ID: 38910444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular RH blood group typing of serologically D-/CE+ donors: the use of a polymerase chain reaction-sequence-specific primer test kit with pooled samples.
    Londero D; Fiorino M; Miotti V; de Angelis V
    Immunohematology; 2011; 27(1):25-8. PubMed ID: 22356483
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RHD variants in Flanders, Belgium.
    Van Sandt VS; Gassner C; Emonds MP; Legler TJ; Mahieu S; Körmöczi GF
    Transfusion; 2015 Jun; 55(6 Pt 2):1411-7. PubMed ID: 25413499
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Validation of a hospital-laboratory workstation for immunohematologic methods.
    Schoenfeld H; Pretzel KJ; von Heymann C; Neuner B; Kalus U; Kiesewetter H; Pruss A
    Transfusion; 2010 Jan; 50(1):26-31. PubMed ID: 19709392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is current serologic RhD typing of blood donors sufficient for avoiding immunization of recipients?
    Krog GR; Clausen FB; Berkowicz A; Jørgensen L; Rieneck K; Nielsen LK; Dziegiel MH
    Transfusion; 2011 Nov; 51(11):2278-85. PubMed ID: 21569040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-D immunization by DEL red blood cells.
    Wagner T; Körmöczi GF; Buchta C; Vadon M; Lanzer G; Mayr WR; Legler TJ
    Transfusion; 2005 Apr; 45(4):520-6. PubMed ID: 15819672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-D reagents should be chosen accordingly to the prevalence of D variants in the obstetric population.
    Lukacevic Krstic J; Dajak S; Bingulac-Popovic J; Dogic V; Mratinovic-Mikulandra J
    J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28649781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variant RHD Types in Brazilians With Discrepancies in RhD Typing.
    Campos FC; Mota MA; Aravechia MG; Torres KB; Bub CB; Kutner JM; Castilho L
    J Clin Lab Anal; 2016 Nov; 30(6):845-848. PubMed ID: 27076392
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serologic findings of RhD alleles in Egyptians and their clinical implications.
    Hussein E; Teruya J
    Transfus Apher Sci; 2014 Oct; 51(2):184-7. PubMed ID: 25219636
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial D and weak D: can they be distinguished?
    Daniels G; Poole G; Poole J
    Transfus Med; 2007 Apr; 17(2):145-6. PubMed ID: 17430473
    [No Abstract]   [Full Text] [Related]  

  • 38. In-frame triplet deletions in RHD alter the D antigen phenotype.
    Flegel WA; Eicher NI; Doescher A; Hustinx H; Gowland P; Mansouri Taleghani B; Petershofen EK; Bauerfeind U; Ernst M; von Zabern I; Schrezenmeier H; Wagner FF
    Transfusion; 2006 Dec; 46(12):2156-61. PubMed ID: 17176329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Resolving variable maternal D typing using serology and genotyping in selected prenatal patients.
    Clarke G; Hannon J; Berardi P; Barr G; Cote J; Fallis R; Alport T; Lane D; Petraszko T; Ochoa G; Goldman M
    Transfusion; 2016 Dec; 56(12):2980-2985. PubMed ID: 27611891
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular basis of D variants between Uigur and Han blood donors in Xinjiang.
    Li Q; Ye LY; Guo ZH; Zhang YX; Wang LL; Zhu ZY
    Transfus Med; 2008 Jun; 18(3):199-203. PubMed ID: 18598284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.